Study Comparing Belrestotug and Dostarlimab with Placebo and Pembrolizumab in Untreated Patients with High PD-L1 Non-Small Cell Lung Cancer | Clinical Trial

Study Comparing Belrestotug and Dostarlimab with Placebo and Pembrolizumab in Untreated Patients with High PD-L1 Non-Small Cell Lung Cancer | Clinical Trial | Right2Hope